Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Personalized Neoantigen MRNA Vaccine RGL-270 Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients

NCT06685653 is registered in ClinicalTrials.gov with Nanjing Tianyinshan Hospital as lead sponsor.

NCT NCT06685653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06685653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Personalized Neoantigen MRNA Vaccine RGL-270 Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients
Lead sponsor
Nanjing Tianyinshan Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
Not reported
Completion date
Not reported
Enrollment
65 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc